Home Faculty meeting CDC Panel Tackles Who Needs COVID Vaccine Booster

CDC Panel Tackles Who Needs COVID Vaccine Booster


By the associated press

A group of influential advisers from the Centers for the Disease Control and Prevention met on Wednesday to debate which Americans should receive COVID-19 booster shots and when – an issue that has proven to be more controversial than the Biden administration does. apparently had foreseen it.

The meeting came days after another advisory group – this one serving the Food and Drug Administration – overwhelmingly rejected a sweeping White House plan to distribute third injections to almost everyone. Instead, that panel approved booster doses of the Pfizer vaccine only for the elderly and those at high risk of contracting the virus.

While COVID-19 vaccines continue to offer strong protection against serious illness, hospitalization and death, immunity against milder infections appears to drop months after vaccination.

The FDA advisory group’s decision last week was just the first hurdle as the government sets its recall policy. The FDA itself has yet to decide whether it agrees with its advisers’ recommendation and will authorize the Pfizer boosters.

If so, then the CDC must recommend who should receive the additional injections after hearing its own advisory committee on immunization practices, whose meeting was scheduled to last until Thursday.

The priority remains to vaccinate the unvaccinated, who the CDC says account for the vast majority of COVID-19 cases, now reaching levels not seen since last winter. About 182 million Americans are fully immunized, or nearly 55% of the total population.

“I would like to point out that in September 2021 in the United States, deaths from COVID-19 are largely preventable by vaccination with the primary series of one of the three available vaccines,” said Dr Matthew Daley , researcher at Kaiser Permanente Colorado. and advisor to the CDC who opened Wednesday’s meeting.

Much of the discussion at the meeting was to focus on who is considered to be at risk high enough for an additional dose – for example, whether healthcare workers who are continually exposed to the virus should be eligible for boosters.

Another question was how many months after the second injection the booster should be given. Scientists have talked about six or eight months.

Many experts are torn by the need for reminders as they see the COVID-19 vaccines working as intended. It is normal for anti-virus antibodies to decrease months after vaccination. Even then, the body has backup defenses against the virus.

Part of the government’s calculation is whether preventing ‘breakthrough’ infections in fully vaccinated people could help curb the transmission of the virus, protect young children who are not yet eligible for vaccination, and ease the burden. overwhelmed health systems.

The government will decide at a later date whether to allow additional doses of Moderna or Johnson & Johnson vaccines.


The Associated Press’s Department of Health and Science receives support from the Department of Science Education at Howard Hughes Medical Institute. The AP is solely responsible for all content.


Please enter your comment!
Please enter your name here